KENNEY CHRISTOPHER JOHN sold XENE
March 13, 2026 · Form 4 insider transaction
KENNEY CHRISTOPHER JOHN sold 1,410 shares of Xenon Pharmaceuticals Inc. at $55.23 per share, a transaction worth $77.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,410
Price
$55.23
Total value
$77.9K
InsiderKENNEY CHRISTOPHER JOHN
RoleOfficer
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateMarch 13, 2026
Filing dateMarch 13, 2026
Shares owned after7,069
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.